Adenosine prevents activation of transcription factor NF-κB and enhances activator protein-1 binding activity in ischemic rat heart

Surgery

Volumn 127, Issue 2, 2000, Pages 161-169

  Li, Chuanfu ^b   Tuanzhu, Ha ^b   Liping, Liu ^b   Browder, William ^b   Kao, Race L ^a  

^a East Tennessee State University   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DERIVATIVE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TRANSCRIPTION FACTOR AP 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; DRUG EFFECT; ELECTROPHORETIC MOBILITY; HEART MUSCLE ISCHEMIA; HEART PROTECTION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; RAT; WESTERN BLOTTING;

EID: 0012525728     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1067/msy.2000.101582     Document Type: Article

References (44)

1. 1. Bozkurt B, Kribbs SB, Clubb FJ Jr, Michael LH, Didenko VV, Hormsby PJ, et al. Pathophysiologically relevant concentrations of tumor necrosis factor-α promote progressive left ventricular dysfunction and remodeling in rats. Circulation 1998;97:1382-91.
2. 2. Kubota T, McTiernan CF, Frye CS, Slawson SE, Lemster BH, Koretsky AP, et al. Dilated cardiomyopathy in transgenic mice with cardiac-specific overexpression of tumor necrosis factor-alpha. Circ Res 81:627-35,1997.
3. 3. Kubota T, McTiernan CF, Frye CS, Demetris AJ, Feldman AM. Cardiac-specific overexpression of tumor necrosis factor-alpha causes lethal myocarditis in transgenic mice. J Card Fail 3:117-24,1997.
4. 4. Bryant D, Becker L, Richardson J, Shelton J, Franco F, Peshock R, et al. Cardiac failure in transgenic mice with myocardial expression of tumor necrosis factor-alpha. Circulation 1998;97:1375-81.
5. 5. Meldrum, DR, Cain BS, Cleveland JC, Meng X, Ayala A, Harken AH. Adenosine decreases post-ischemic myocardial TNFα anti-inflammatory implications for preconditioning and transplantation. Immunology 1997;92:472-7.
6. 6. Cain BS, Meldrum DR, Dinarello CA, Meng X, Banerjee A, Harken AH. Adenosine reduces cardiac TNF-α production and human myocardial injury following ischemia-reperfusion. J Surg Res 1998;76:117-23.
7. 7. Parmely MJ, Zhou WW, Edwards CK III, Borcherding DR, Silverstein R, Morrison DC. Adenosine and a related carbocyclic nucleoside analogue selectively inhibit tumor necrosis factor-α production and protect mice against endotoxin challenge. J Immunol 1993;151:389-96.
8. 8. Hasko G, Szabo C, Nemeth NH, Kvetan V, Pastores SM, Vizi ES. Adenosine receptor agonists differentially regulate IL-10, TNF-α, and nitric oxide production in RAW 264.7 macrophages and in endotoxemic mice. J Immunol 1996;157:4634-40.
9. 3 receptor agonists inhibit murine macrophage tumor necrosis factor-alpha production in vitro and in vivo. Cell Mol Biol 1997;43:345-9.
10. 10. Ritchie PK, Spangelo BL, Krzymowski DK, Rossiter TB, Kurth E, Judd AM. Adenosine increases interleukin 6 release and decreases tumor necrosis factor release from rat adrenal zona glomerulosa cells, ovarian cells, anterior pituitary cells, and peritoneal macrophages. Cytokine 1997;9:187-98.
11. 11. Wagner DR, Combes A, McTiernan C, Sanders VJ, Lemster B, Feldman AM. Adenosine inhibits lipopolysaccharide-induced cardiac expression of tumor necrosis factor-alpha. Circ Res 1998;82:47-56.
12. 12. Baeuerle PA, Baltimore D. NF-κB: ten years after. Cell 1996;87:13-20.
13. 13. Baldwin AS Jr. The NF-κB and IκB proteins: new discoveries and insights. Annu Rev Immunol 1996;14:649-83.
14. 14. Angel P, Karin M. The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. Biochim Biophys Acta 1991;1072:129-57.
15. 15. Schreck R, Albermann K, Bacuerle PA. Nuclear factor kappa B: an oxidative stress-responsive transcription factor of eukaryotic cells. Free Rad Res Comms 1992;17:221-37.
16. 16. Devary Y, Gottlieb RA, Lau LF. Rapid and preferential activation of the c-jun gene during the mammalian UV response. Mol Cell Biol 1991;11:2804-11.
17. 17. Meyer M, Schreck R, Bacuerle P. Hydrogen peroxide and antioxidants have opposite effects on activation of NF-κB and AP-1 in intact cells: AP-1 as secondary antioxidant responsive factor. EMBO J 1993;12:2005-15.
18. 18. Li C, Browder W, Kao RL. Early activation of transcription factor NF-κB during ischemia in perfused rat heart. Am J Physiol 1999;276:H543-52.
19. 19. Brand T, Sharma HS, Fleischmann KE, Duncker DJ, McFalls EO, Verdouw PD, et al. Protooncogene expression I porcine myocardium subjected to ischemia and reperfusion. Circ Res 1992;71:1351-60.
20. 20. Das DK, Morani H, Maulik N, Engelman RM. Gene expression during myocardial adaptation to ischemia and reperfusion. Ann NY Acad Sci 1994;723:292-307.
21. 21. Chandrasekar B, Freeman GL. Induction of nuclear factor κB and activation protein 1 in postischemic myocardium. FEBS Lett 1997;401:30-34.
22. 22. Kao RL, Conti VR, Williams EH. Effect of temperature during potassium arrest on myocardial metabolism and function. J Thorac Cardiovasc Surg 1982;84:243-9.
23. 23. Dunn JA, Li C, Ha T, Kao RL, Browder W. Therapeutic modification of nuclear factor κB binding activity and tumor necrosis factor-α gene expression during acute biliary pancreatitis. Am Surg 1997;63:1036-44.
24. 24. Williams DL, Ha T, Li C, Kalbfleisch JH, Laffan JJ, Ferguson DA. Inhibiting early activation of tissue nuclear factor-κB and nuclear factor interleukin 6 with (1→3) β-D-glucan increases long-term survival in polymicrobial sepsis. Surgery 1999;126:54-65.
25. 25. Bouma MG, Stad RK, Van den Wildenberg FAKM, Buurman WA. Differential regulatory effects of adenosine on cytokine release by activated human monocytes. J Immunol 1994;153:4159-68.
26. 2 receptors on rat Kupffer cells. Hepatology 1994;19:1445-52.
27. 27. Bouma MG, vanden Wildenberg FAJM, Buurman WA. Adenosine inhibits cytokine release and expression of adhesion molecules by activated human endothelial cells. Am J Physiol 1996;270:C522-9.
28. 28. Kacimi R, Karliner JS, Koudssi F, Long CS. Expression and regulation of adhesion molecules in cardiac cells by cytokines, response to acute hypoxia. Circ Res 1998;82:576-86.
29. 29. Morishita R, Sugimoto T, Aoki M, Kida I, Tomita N, Moriguchi A, et al. In vivo transcription of cis element "decoy" against nuclear factor-kappa B binding site prevents myocardial infarction. Nat Med 1997;3:894-9.
30. 30. Sawa Y, Morishita R, Suzuki K, Kagisaki K, Kaneda Y, Maeda K, et al. A novel strategy for myocardial protection using in vivo transfection of cis element 'decoy' against NF-κB binding site: evidence for a role of NF-κB in ischemia-reperfusion injury. Circulation 1997;96(suppl II):II-280-5.
31. 31. Chandrasekar B, Etreitman JE, Colston JT, Freeman GL. Inhibition of nuclear factor κB attenuates proinflammatory cytokine and inducible nitric-oxide synthase expression in postischemic myocardium. Biochim Biophys Acta 1998; 1406:91-106.
32. 32. Herskowitz A, Choi S, Ansari AA, Wesselingh S. Cytokine mRNA expression in postischemic/reperfusion myocardium. Am J Pathol 1995;146:419-28.
33. 33. Shames BD, Meng X, Barton H, Medrum DR, Pulido EJ, Cain BS, et al. Myocardial ischemia before reperfusion activates cardiocyte nuclear factor kappa B and induces production of tumor necrosis factor alpha. Surg Forum 1998;231-3.
34. 34. Le Bail O, Schmidt-Ullrich R, Israël A. Promoter analysis of the gene encoding the IκBα/MAD3 inhibitor of NF-κB: positive regulation by members of the rel/NF-κB family. EMBO J 1993;12:5043-9.
35. 35. Chiao PJ, Miyamoto S, Verma IM. Autoregulation of IκBα activity. Proc Natl Acad Sci USA 1994;91:28-32.
36. 36. Yao KS, Xanthoudakis S, Curran T, O'Dwyer PJ. Activation of AP-1 and of nuclear redox factor, Ref-1, in the response of HT29 colon cancer cells to hypoxia. Mol Cell Biol 1994;14:5997-6003.
37. 37. Rupec RA, Baeuerle PA. The genomic response of tumor cells to hypoxia and reoxygenation differential activation of transcription factors AP-1 and NF-κB. Eur J Biochem 1995;234:632-40.
38. 38. Choi HS, Moore DD. Induction of c-fos and c-jun gene expression by phenolic antioxidants. Mol Endocrinol 1993;7:1596-602.
39. 39. Peng M, Huang L, Xiu ZJ, Huang WH, Askari A. Oxidantinduced activations of nuclear factor-kappa B and activator protein-1 in cardiac myocytes. Cell Mol Biol Res 1995;41:189-97.
40. 40. Ely SW, Berne RM. Protective effects of adenosine in myocardial ischemia. Circulation 1992;85:893-904.
41. 41. Cronstein BN. Adenosine, an endogenous anti-inflammatory agent. J Appl Physiol 1994;76:5-13.
42. 42. Schenk H, Klein M, Erdbrügger W, Dröge W, Schulze-Osthoff K. Distinct effects of thioredoxin and antioxidants on the activation of transcription factors NF-κB and AP-1. Proc Natl Acad Sci USA 1994;91:1672-6.
43. 3 adenosine receptors. J Immunol 1996;156:3435-42.
44. 44. Roberts JL, Messerschmidt HW, Kao RL. The role of adenosine in cardioplegia. In: Chiu RC-J, ed. Cardioplegia: Current Concepts and Controversies. Austin, TX: RG Landers;1993:42-51.